CSRNP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.508200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.720200E-01
Normal-vs-Stage2
8.616600E-01
Normal-vs-Stage3
9.166300E-02
Normal-vs-Stage4
2.665200E-01
Stage1-vs-Stage2
4.315600E-01
Stage1-vs-Stage3
6.974000E-02
Stage1-vs-Stage4
4.099000E-01
Stage2-vs-Stage3
1.575410E-01
Stage2-vs-Stage4
1.049180E-01
Stage3-vs-Stage4
3.685500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.574400E-01
Normal-vs-AfricanAmerican
8.641600E-01
Normal-vs-Asian
4.847000E-01
Caucasian-vs-AfricanAmerican
7.293600E-01
Caucasian-vs-Asian
1.875220E-01
AfricanAmerican-vs-Asian
3.080000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.848800E-01
Normal-vs-Female
9.035000E-01
Male-vs-Female
7.214000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.924800E-01
Normal-vs-Age(41-60Yrs)
5.372200E-01
Normal-vs-Age(61-80Yrs)
7.395800E-01
Normal-vs-Age(81-100Yrs)
2.785600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.037000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.030600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.463900E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.198140E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.256700E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.280000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.972600E-01
Normal-vs-Daily Drinker
5.112800E-01
Normal-vs-Weekly Drinker
9.353800E-01
Normal-vs-Occasional Drinker
8.879800E-01
Normal-vs-Social Drinker
5.835400E-01
Non Drinker-vs-Daily Drinker
5.043200E-01
Non Drinker-vs-Weekly Drinker
6.510200E-02
Non Drinker-vs-Occasional Drinker
2.826100E-02
Non Drinker-vs-Social Drinker
4.937700E-03
Daily Drinker-vs-Weekly Drinker
2.332600E-01
Daily Drinker-vs-Occasional Drinker
1.473780E-01
Daily Drinker-vs-Social Drinker
3.605700E-02
Weekly Drinker-vs-Occasional Drinker
9.425600E-01
Weekly Drinker-vs-Social Drinker
4.272600E-01
Occasional Drinker-vs-Social Drinker
4.001800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.743830E-01
Normal-vs-Grade 2
5.935700E-02
Normal-vs-Grade 3
5.662200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.412800E-01
Grade 1-vs-Grade 3
4.672800E-01
Grade 1-vs-Grade 4
1.743830E-01
Grade 2-vs-Grade 3
8.040200E-01
Grade 2-vs-Grade 4
5.935700E-02
Grade 3-vs-Grade 4
5.662200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.713200E-01
Normal-vs-NonDiabetic
8.777400E-01
Diabetic-vs-NonDiabetic
6.504800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.264000E-01
Normal-vs-NoPancreatitis
8.595200E-01
Pancreatitis-vs-NoPancreatitis
7.119600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.441000E-01
Normal-vs-N1
9.193200E-01
N0-vs-N1
9.373000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.345000E-01
Normal-vs-TP53-NonMutant
8.228200E-01
TP53-Mutant-vs-TP53-NonMutant
3.063400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
